193 related articles for article (PubMed ID: 35672530)
21. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry.
Riecke K; Müller V; Neunhöffer T; Park-Simon TW; Weide R; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Wuerstlein R; Denkert C; Decker T; Fehm T; Nekljudova V; Rey J; Loibl S; Laakmann E; Witzel I
ESMO Open; 2023 Jun; 8(3):101213. PubMed ID: 37075697
[TBL] [Abstract][Full Text] [Related]
22. New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast Cancer Res Treat; 2021 Apr; 186(2):453-462. PubMed ID: 33392845
[TBL] [Abstract][Full Text] [Related]
23. [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
Zhang T; Li Q; Xu B; Zhang P; Yuan P; Ma F; Wang J; Fan Y
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):697-702. PubMed ID: 25564062
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with bone metastasis in breast cancer: a systematic review and meta-analysis.
Liu H; Zhang X; Zhang S; Wang X; Yu S
Ann Palliat Med; 2021 Apr; 10(4):4435-4452. PubMed ID: 33966394
[TBL] [Abstract][Full Text] [Related]
25. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
26. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
27. Association of the neutrophil-to-lymphocyte ratio with brain metastases in Hispanic breast cancer patients.
Cacho-Díaz B; Cortes-Ortega MD; Reynoso-Noverón N; Wegman-Ostrosky T; Arriaga-Canon C; Bargalló-Rocha JE
Cancer Treat Res Commun; 2021; 29():100452. PubMed ID: 34517195
[TBL] [Abstract][Full Text] [Related]
28. Role of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain Metastases.
Cacho-Díaz B; Spínola-Maroño H; Reynoso N; González-Aguilar A; Mohar-Betancourt A
Clin Breast Cancer; 2019 Apr; 19(2):e394-e398. PubMed ID: 30745110
[TBL] [Abstract][Full Text] [Related]
29. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of breast cancer subtypes in elderly patients.
Bergen ES; Tichy C; Berghoff AS; Rudas M; Dubsky P; Bago-Horvath Z; Mader RM; Exner R; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
Breast Cancer Res Treat; 2016 May; 157(1):91-9. PubMed ID: 27107570
[TBL] [Abstract][Full Text] [Related]
31. Interactive effects of molecular subtypes with tumor size and extracranial metastatic pattern on risk of brain metastasis in breast cancer patients: A population-based study.
Shen B; Li J; Yang M; Liu K; Zhang J; Li W; Zhang Y; Wang K
Cancer Med; 2023 Mar; 12(6):6547-6557. PubMed ID: 36353772
[TBL] [Abstract][Full Text] [Related]
32. Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim YB; Chang JS; Choi DH; Kim H; Park YH; Kim DY; Kim TH; Kwon J; Kang KM; Chung WK; Kim KS; Kim IA
Breast; 2021 Dec; 60():272-278. PubMed ID: 34814043
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review.
Hackshaw MD; Danysh HE; Henderson M; Wang E; Tu N; Islam Z; Ladner A; Ritchey ME; Salas M
BMC Cancer; 2021 Aug; 21(1):967. PubMed ID: 34454469
[TBL] [Abstract][Full Text] [Related]
34. Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thézenas S; Jacot W
Int J Cancer; 2016 Nov; 139(10):2299-311. PubMed ID: 27464303
[TBL] [Abstract][Full Text] [Related]
35. The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Gori S; Puglisi F; Moroso S; Fabi A; La Verde N; Frassoldati A; Tarenzi E; Garrone O; Vici P; Laudadio L; Cretella E; Turazza M; Foglietta J; Leonardi V; Cavanna L; Barni S; Galanti D; Russo A; Marchetti F; Valerio M; Lunardi G; Alongi F; Inno A
Clin Breast Cancer; 2019 Aug; 19(4):e501-e510. PubMed ID: 31204290
[TBL] [Abstract][Full Text] [Related]
36. Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors.
Tabouret E; Metellus P; Tallet-Richard A; Figarella-Branger D; Charaffe-Jauffret E; Viens P; Gonçalves A
Anticancer Res; 2013 May; 33(5):2159-67. PubMed ID: 23645770
[TBL] [Abstract][Full Text] [Related]
37. Lower incidence but more aggressive behavior of right sided breast cancer in Pakistani women: does right deserve more respect?
Fatima N; Zaman MU; Maqbool A; Khan SH; Riaz N
Asian Pac J Cancer Prev; 2013; 14(1):43-5. PubMed ID: 23534768
[TBL] [Abstract][Full Text] [Related]
38. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
39. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]